Background Pancreatic fistula (PF) is considered to be the main cause of morbidity after pancreaticoduodenectomy (PD). A recent study from our institution suggested the risk for pancreatic fistula after distal pancreatectomy to be closely related to the pancreatic remnant volume (PRV). The hypothesis was formulated that after PD the PRV is an important determinant of the risk for PF formation. Method All patients undergoing PD between September 2007 and November 2010 at the Karolinska University Hospital Stockholm were included. Preoperative multidetector computed tomography (CT) or magnetic resonance imaging (MRI) was used to calculate the PRV and the pancreatic duct width (PDW) at the alleged resection line.
Introduction
Pancreaticoduodenectomy (PD) is a complex surgical procedure associated with significant postoperative morbidity [1] [2] [3] [4] . Pancreatic fistula (PF) due to leakage from the pancreatico-alimentary anastomosis is generally recognized as the main factor for morbidity. Several risk factors in the development of an insufficient pancreaticojejunostomy have been proposed and subsequently validated, such as a soft pancreas, fatty pancreas, and small caliber pancreatic duct [5] [6] [7] [8] [9] [10] . Most of these factors can be objectively assessed at the time of the operation and are, by necessity, to a certain degree observer-dependent.
One potentially fertile approach to the problem would be to explore a variety of preoperative options that could clearly identify those patients who subsequently might be exposed to a high risk of PF. With such information, the patient can be counseled regarding a higher postoperative risk, the surgical strategy may be altered (e.g., sub-/total pancreatectomy in an individual with co-morbidity not coping with postoperative PF), and the best surgical competence for this difficult anastomosis could be planned for.
Modern radiology techniques have emerged to facilitate risk prediction in the preoperative setting [7, 8] . A recent study from our institution suggested an increased PF risk after a distal pancreatectomy (DP) in patients with a large pancreatic remnant volume (PRV) [11] . A hypothesis was subsequently formulated that the PRV could be an important determinant of PF rate after PD. Because PD performed in a high-volume center is a highly standardized procedure involving transection of the neck of the gland at the left border of the superior mesenteric vein, the rationale was to calculate the PRV during the preoperative evaluation. Thus the aim of the present study was to test the hypothesis that the PRV, preoperatively estimated, could be an important determinant of PF rate after PD.
Methods
The study cohort consisted of all patients undergoing PD between September 2007 and November 2010 at the Karolinska University Hospital, Stockholm, Sweden. This database was collected prospectively according to a standardized protocol, and it incorporates all pre-, intra-and postoperative information relevant to the management of similar patients. Patients in whom the pancreas was not transected at the left border of the superior mesenteric vein (e.g., those undergoing subtotal resection of the pancreas leaving only a small remnant close to the splenic hilum), a difference in procedure that would compromise the current estimates of the PRV, were excluded. Furthermore, we censored the patients who received neoadjuvant (downstaging) chemotherapy prior to PD, given the potential confounding impact of such therapies on gland size and function. The potential impact on the radiological and histomorphological effects of modern neoadjuvant regimens is the subject for a separate study protocol.
Radiological analyses
Preoperative contrast-enhanced multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) investigations were analyzed.
CT protocol
The preoperative CT images were acquired with contrastenhanced MDCT scanners, according standard pancreas imaging protocols. The slice thickness varied between 3 mm (with a reconstruction interval of 1.5 mm) and 5 mm (with a reconstruction interval of 2.5-5 mm). Intravenous nonionic contrast agent was used for parenchymatous and venous phases.
MRI protocol
Contrast-enhanced MRI with gadolinium contrast medium was performed in 1-T or 1.5-T scanners according to standard pancreas imaging protocols, including a contrast enhanced, fat-suppressed 3-D T1-weighted gradient echo sequence acquired in the parenchymatous and venous phases.
Volumetric measurements
The volumetric analyses were performed in the axial plane and in the contrast phase with the best delineation of the parenchyma from the surrounding vessels. In the majority of cases it corresponded to the parenchymal phase. Two radiologists who were blinded to the patients' postoperative courses calculated in consensus the PRV to the left of the alleged transection line. The volume was calculated by both radiologists, and the inter-individual variation was \10 %. The main pancreatic duct width (PDW) was measured at the level of the alleged transection line. The PRV was analyzed on a Voxar 3D workstation (Toshiba Medical Visualization Systems, Edinburgh, UK) with 3D segmentation and volume calculation (Fig. 1) . The caliberwidth of the main pancreatic duct was measured at the resection plane. The calculations of PRV and PDW in 167 patients were done using MDCT images and in the remaining patients using MRI images. In ten patients both MDCT and MRI images were available (performed within a time frame of B1 month) for comparison of the two protocols.
Surgical procedure
Preoperative management was standardized as far as possible. All patients received a single dose of intravenous antibiotics (1.5 g of cefuroxime and metronidazole, respectively) and octreotide (100 lg 9 3 Sandostatin, Novartis Pharm GmbH, Nurnberg, Germany) prior to the operation. Octreotide was discontinued on day 5 or when the patient started to feed orally. A conventional PD with extended lymph node dissection (except for the lymph nodes to the left of the superior mesenteric artery) was performed in all patients [12] . The pancreas was transected at the left border of the superior mesenteric vein. An end-to-side duct-to-mucosa pancreaticojejunostomy was completed, with the inner layer of the anastomosis completed with 5-0 or 6-0 sutures (Pronova, Ethicon, Somerville, NJ). The outer layer, consisting of the remnant pancreas parenchyma and the seromuscular layer of the jejunum, were coated with 4-0 or 5-0 sutures (see above). Two intra-abdominal drains were inserted, one close to the pancreaticojejunostomy and one near the hepaticojejunostomy. All drain fluids and other collections were analyzed daily for hemoglobin, bilirubin, and amylase.
Definition of pancreatic fistula
Patients were categorized as having developed a grade A, B, or C fistula, based on the definitions of the International Study Group on Pancreatic Fistula (ISGPF) [13] . The presence of a biochemical leak, regarded as grade A, was defined as output containing pancreatic amylase on or after the third postoperative day from an operatively positioned drain displaying pancreatic amylase more than three times the upper serum reference value. A clinically significant grade B pancreatic fistula was considered present if any therapeutic intervention was required; if severe clinical sequelae occurred, a grade C fistula was considered to be present [14] . The overall postoperative morbidity was classified according to the modified Clavien-Dindo scoring system [15] .
Sample size
To test the null hypothesis that there is no difference in the PF rate between patients with large and small remnant volumes, we based our calculations on data retrieved from our own recent study with the PF risk of 57 % for large remnant volume compared to 21 % for small remnant volume after DP [11] . In our database, the risk of PF after PD is 0.4 compared to the risk after DP. To detect a difference in fistula rates for large and small remnant volume from 26 to 10 % after PD, respectively, with a power of 
Statistics
The statistical analysis was performed with SPSS 19.0 software (SPSS Inc., Chicago, IL). Data are presented as frequencies, mean (± standard deviation) or median, and interquartile ranges (IQR). All tests of statistical significance were two-sided, and a significant difference was considered to occur at an alpha less than 0.05. Pearson's v 2 was used to perform significance tests for categorical values as well as the Spearman correlation test. Logistic regression analyses were performed to identify risk factors for pancreatic fistulae, with and without simultaneous adjustment for competing risk factors. Crude associations were studied in a univariate model, which was followed by a multivariate analysis of the respective factors. The associations were presented as odds ratios with 95 % confidence intervals.
Results
After excluding 15 patients who received neoadjuvant chemotherapy or had subtotal pancreatectomies, 182 patients (94 males and 88 females) with a median age of 67 years (range: 22-87 years) were eligible for the study. The underlying diagnosis was malignant in 144 patients (79.1 %) and benign in 38 patients (20.9 %). A preoperative American Society of Anesthesiologists (ASA) score of II was recorded for 100 patients (54.9 %) and an ASA score of III, for 55 (30.2 %). The details of the preoperative and intraoperative patient characteristics are presented in Table 1 .
In total, 120 patients (65.9 %) experienced postoperative complications (Clavien [1) ( Table 2) , and 31 (17 %) of them had a severe complication, defined as Clavien C3b. The most common surgical complication was a PF, which was observed in 38 patients (20.9 %) and 14 of these were grade C fistulas. Eight of 24 patients with intra-abdominal abscesses had no apparent pancreatic leakage (no drainage of amylase-containing fluid). The occurrence of a PF increased the mean period of hospital care from 14.3 ± 7.6 to 30 ± 27.7 days (OR 1.07, 95% CI 1.03-1.10, P \ 0.01). Twenty-four (13 %) patients required reoperation. Eleven were reoperated due to a grade C fistula and seven of these required several procedures. The other 14 were early reoperations for bile leakage (4), intra-abdominal bleeding (3), intraluminal bleeding (4), and later wound dehiscence (3). Three (1.6 %) patients died on the 9th, 10th, and 23rd postoperative day, respectively. Two had a PF with uncontrollable hemorrhage, and one died suddenly after myocardial infarction without postoperative complications.
The mean PRV was calculated as 36.9 ± 15.5 cm 3 ( Fig. 2) . Mean pancreatic duct width (PDW), measured at the left border of the superior mesenteric vein, was 4.6 ± 3.0 mm (Fig. 3) . Corresponding values at the 25th, median, and 75th percentiles were 24.9, 35.2, and 46.7 cm 3 for PRV and 2.1, 3.9, and 7.1 mm for PDW, respectively. In 10 patients both MDCT and MRI images were available (performed within a time frame of B1 month) for independent calculations of respective variables. We calculated the mean PRV at the MDCT to be 34.4 (SD 10.0) cm 3 and measured through the corresponding MRI images 33.3 (SD 8.4) cm 3 . This gives a Spearman correlation coefficient of 0.9 between the estimates. Risk factor analysis Logistic regression analyses were performed to identify potential determinant variables, including the estimated PRV and PDW based on categorical variables as delineated in Table 3 . Pancreatic fistulas occurred significantly more often in patients with a large PRV and a small PDW at the level of the estimated resection line. No patient with a PRV at the first quartile, i.e., below 24.9 cm 3 , developed a clinically significant PF-i.e., ISGPF grade B or C. Similarly, only one patient with a calculated PDW of 7.1 mm or higher (75th percentile or larger) developed a PF (Figs. 2,  3 ). In the multivariate analyses, a large PRV or small PDW, both significantly and independently, increased the risk for PF (Table 3) .
The combination of all aspects in a potentially clinically relevant scoring system based on gland volume and duct diameter calculations is displayed in Table 4 . When the respective gland-duct characteristics were divided, according to 25th, the 50th, and the 75th percentiles into groups based on the sum of scores, three risk categories could be defined (from a low risk B1 to a high risk C4). Hence a similar preoperative scoring system could be used to calculate the risk for clinically significant PF to be 38.5 %, if the sum was C4, compared to 0 %, if the corresponding figure was B1 (P \ 0.01).
Discussion
This large, well-controlled, single-institution study addresses the clinically important topic of whether it is possible to identify preoperatively those patients who will develop anastomotic leakage from the pancreaticojejunostomy after a standardized pancreaticoduodenectomy. On scrutinizing a number of well-defined patient-specific, disease-specific, and radiological criteria, we observed that the pancreatic remnant volume (PRV) and pancreatic duct width (PDW) at the established transection line, significantly and independently influenced the risk for PF. One very important precondition for clinical research in the field of pancreatic surgery is the availability and recognition of a widely accepted classification system for PF. It is clear that the clinical impact of grade A fistula can be rightfully questioned [16] , but we observed the same degree of association between the preoperative estimates and the incidence of clinically significant grade B and C fistulae as well. Obviously, the PF rate and morbidity in general are substantial after PD, as seen in this series, as well as in many other recent reports from well-controlled, prospectively collected data sets captured from high-volume centers [17] . It is also evident, although complication rates are high, that these complications can be managed successfully with low in-hospital mortality and a decent length of hospital stay.
The critical issue this study addresses is whether we can define a risk profile for each individual patient that would allow for preparatory measures to be taken to minimize the risk of PF. The issues relevant to the choice and anatomic location of the pancreatico-alimentary anastomoses have been considered [10, 18] , but the selection of the type of anastomosis does not appear to be the tool with which the problem can finally be solved. Instead, novel designs and techniques for the construction of the pancreatico-alimentary anastomosis have to be further explored [18] . Moreover, the opinions concerning the leakage prevention effect of inhibiting pancreatic secretion by administering somatostatin analogs have not reached the level of consensus that would justify the routine clinical use of such analogs [19, 20] . In this series of patients we chose to routinely administer a somastotatin analog in order to standardize the clinical research conditions. One great challenge for researchers is to make appropriate selection of patients to be randomized into prospective studies. Every study focusing on pancreatic leakage and its prevention has to enrol patients who are at increased risk of anastomotic dehiscence, otherwise the impact of a certain intervention will be diluted and clinically relevant preventive effects may be obscured. Hitherto this has been a problem that has not received the attention it deserves in many studies of different interventions of surgical as well as pharmacotherapeutic nature. However, going forward, a study's design will be flawed if it its endpoints are leakage prevention and minimization and it enrols patients with certain radiological gland characteristics suggestive of a low risk of PF. From a patients' point of view, every participating patient has the right to accurate information about risks before consenting to an operation or trial. From a research ethics perspective, it is far from optimal to leave the final decision and randomization to the discretion of the operating surgeon.
Two principles underlie the findings of the present study. First, with an increasing degree of fibrosis of the gland, its volume declines and the duct diameter increases in both relative and absolute terms [21] . How closely preoperative assessments are related to the surgeon's intraoperative assessment of the texture of the gland and diameter of the main pancreatic duct needs to be addressed in a larger patient cohort. Second, the larger the gland, the more digestive juice can be produced per unit time to compromise the healing of the pancreaticojejunostomy. It can be argued that this rationale is not corroborated by the lack of clear-cut effects of pancreatic juice secretion inhibition on the healing process. However, this topic requires a fresh scientific look based on recently discovered issues relevant to the respective study designs and selection of high-risk study subjects for PF. In this context it is important to bear in mind that PRV includes the volume of the pancreatic duct (i.e., non-functioning parenchyma). In patients with an atrophic parenchyma and a dilated duct, the difference between the total volume and the volume minus the dilated duct may be relatively large. Again, we tried to apply a pragmatic approach to the problem by defining a composite assessment score incorporating cutoff levels of the respective parameters. From a clinical utility perspective, measurement of the entire remnant volume is achievable, but additional measurement of the volume from which the duct is deducted would be timeconsuming and therefore hard to follow in daily clinical practice.
One limitation of our study relates to the measurement of volumes from CT and MRI images acquired through the use of protocols with different slice thicknesses. However, according to Reiner et al. [22] , although the mean total liver volume decreased with increased slice thicknesses for both CT and MRI, the difference was not significant if the volumetrics were based on slice thicknesses up to 6 mm for CT and 8 mm for MRI. Our CT and MRI protocols were well within those limits. Another important piece of information emerging from the present study was that the original preoperative CT/MRI investigations, performed with different protocols at the primary referring hospitals, could be used to measure PRV and PDW for prediction of PF after PD. Comparatively few of our patients had both a CT and MRI investigation done within a decent time frame (\1 month). However, when making a direct comparison between the PRV estimates we were able to find excellent agreement.
What are the immediate clinical consequences of the present findings? The surgeon-dependency of the outcome of pancreatic surgery is established [10, 23] , although the magnitude of its impact can be discussed within a highvolume center. Adjustments of the predicted risk profile of the pancreatic anastomosis could be made, however, within such institutions to technically optimize the respective steps of the operative procedures. Teaching and clinical training in pancreatic surgery represent a pivotal task for high-volume centers. In the planning and conduct of similar training programs, preoperative risk assessment of the critical parts of the Whipple operation is of particular value, both for the trainee and for the supervisor. In addition, it must be carefully considered whether, in certain situations and preconditions, the choice of a subtotal pancreatectomy is to be preferred, i.e., incorporating the anastomosis only to the tail of the gland, and thus predominantly preserving endocrine function. Moreover, there is room for technical improvements in the CT-based technology whereby the tissue texture could be addressed in more detail. Here, MRI technologies may have advantages that should be further explored. Recent reports using magnetic resonance imaging have suggested that the preoperative signal intensity of the pancreas was related to the subsequent risk for PF [7, 8] . However, similar research protocols have to be developed from a basic platform where the PRV and PDW are given thorough attention.
In conclusion, the present study shows that it is possible and relevant to calculate the PRV and the PDW preoperatively, by using CT and MRI, and thereby predict PF formation after PD.
